Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TARGET: Low-intensity INR in HeartMate 3 LVAD
NCT07081035Phase 4Not yet recruiting
- Sponsor
- Asan Medical Center
- Start
- Oct 2025
- Primary completion
- Oct 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of warfarin in thromboembolism, sponsored by Asan Medical Center. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
warfarin
03
Conditions
thromboembolism
Beyond the preview
Go deeper on NCT07081035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07081035.